Search research articles
Contact Us
Filters
Showing results (351-360 of 379) with videos related to
Page
of 38
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2023
Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
Aurelius Omlin, Richard Cathomas, Gunhild von Amsberg, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Sex and breeding stage differences in neurogenomic profiles reflect hormone signaling in a socially polyandrous shorebird
Tessa Patton, Evan J Buck, Aaron Buechlein Buechlein, et al.
BMC Genomics
|
May 31, 2013
Quantitative trait loci in hop (Humulus lupulus L.) reveal complex genetic architecture underlying variation in sex, yield and cone chemistry
Erin L McAdam, Jules S Freeman, Simon P Whittock, et al.
Clinical Pharmacokinetics
|
July 27, 2022
Influence of Darolutamide on Cabazitaxel Systemic Exposure
Stefan A J Buck, Niels A D Guchelaar, Peter de Bruijn, et al.
Alcoholism, Clinical and Experimental Research
|
June 8, 2001
Alcohol actions on GABA(A) receptors: from protein structure to mouse behavior
S Ueno, R A Harris, R O Messing, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
July 5, 2007
Reader and platform reproducibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners
Tobias Saam, Thomas S Hatsukami, Vasily L Yarnykh, et al.
Molecular Cancer Therapeutics
|
November 29, 2023
Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition
Stefan A J Buck, Annelies Van Hemelryk, Corrina de Ridder, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 21, 2023
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide
Stefan A J Buck, Marinda Meertens, Frederiek M F van Ooijen, et al.
Ebiomedicine
|
November 8, 2021
Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer
Lisanne Mout, Martin E van Royen, Corrina de Ridder, et al.
International Journal of Cancer
|
March 16, 2024
Darolutamide does not interfere with OATP-mediated uptake of docetaxel
Stefan A J Buck, Zahra Talebi, Thomas Drabison, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 379) with videos related to
Sort By:
Page
of 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2023
Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
Aurelius Omlin, Richard Cathomas, Gunhild von Amsberg, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Sex and breeding stage differences in neurogenomic profiles reflect hormone signaling in a socially polyandrous shorebird
Tessa Patton, Evan J Buck, Aaron Buechlein Buechlein, et al.
BMC Genomics
|
May 31, 2013
Quantitative trait loci in hop (Humulus lupulus L.) reveal complex genetic architecture underlying variation in sex, yield and cone chemistry
Erin L McAdam, Jules S Freeman, Simon P Whittock, et al.
Clinical Pharmacokinetics
|
July 27, 2022
Influence of Darolutamide on Cabazitaxel Systemic Exposure
Stefan A J Buck, Niels A D Guchelaar, Peter de Bruijn, et al.
Alcoholism, Clinical and Experimental Research
|
June 8, 2001
Alcohol actions on GABA(A) receptors: from protein structure to mouse behavior
S Ueno, R A Harris, R O Messing, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
July 5, 2007
Reader and platform reproducibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners
Tobias Saam, Thomas S Hatsukami, Vasily L Yarnykh, et al.
Molecular Cancer Therapeutics
|
November 29, 2023
Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition
Stefan A J Buck, Annelies Van Hemelryk, Corrina de Ridder, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 21, 2023
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide
Stefan A J Buck, Marinda Meertens, Frederiek M F van Ooijen, et al.
Ebiomedicine
|
November 8, 2021
Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer
Lisanne Mout, Martin E van Royen, Corrina de Ridder, et al.
International Journal of Cancer
|
March 16, 2024
Darolutamide does not interfere with OATP-mediated uptake of docetaxel
Stefan A J Buck, Zahra Talebi, Thomas Drabison, et al.
Page
of 38